{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:34:47Z","timestamp":1770824087387,"version":"3.50.1"},"reference-count":223,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/pap.0b013e318234ab18","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T08:31:07Z","timestamp":1318408267000},"page":"415-437","source":"Crossref","is-referenced-by-count":87,"title":["Endometrial Carcinomas"],"prefix":"10.1097","volume":"18","author":[{"given":"Carla","family":"Bartosch","sequence":"first","affiliation":[]},{"given":"Jos\u00e9","family":"Manuel Lopes","sequence":"additional","affiliation":[]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R2-1-20210202","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jcp.2009.071225","article-title":"Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.","volume":"63","author":"Clarke","year":"2010","journal-title":"J Clin Pathol"},{"key":"R3-1-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004347-200404000-00002","article-title":"WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract.","volume":"23","author":"McCluggage","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R4-1-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00125480-200303000-00001","article-title":"Biomarkers in diagnostic obstetric and gynecologic pathology: a review.","volume":"10","author":"Nucci","year":"2003","journal-title":"Adv Anat Pathol"},{"key":"R5-1-20210202","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2010.09.001","article-title":"Endometrioid carcinoma of the endometrium: pathologic and molecular features.","volume":"27","author":"Azueta","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"R6-1-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects.","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol"},{"key":"R7-1-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.semdp.2010.09.004","article-title":"Nonendometrioid endometrial carcinomas.","volume":"27","author":"Lim","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"R8-1-20210202","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","article-title":"Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.","volume":"28","author":"Darvishian","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R9-1-20210202","first-page":"569","article-title":"Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus.","volume":"18","author":"Ambros","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R10-1-20210202","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000478-200001000-00026","article-title":"Villoglandular adenocarcinoma of the endometrium.","volume":"24","author":"Ambros","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R11-1-20210202","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ajcp\/111.3.336","article-title":"Clinicopathologic features and genetic alterations in endometrioid carcinoma of the uterus with villoglandular differentiation.","volume":"111","author":"Esteller","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R12-1-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00132583-200005030-00005","article-title":"Villoglandular adenocarcinoma of the endometrium and its differential diagnosis with uterine serous carcinoma.","volume":"5","author":"Ioffe","year":"2000","journal-title":"Pathology Case Rev"},{"key":"R13-1-20210202","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00000478-199811000-00008","article-title":"Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.","volume":"22","author":"Zaino","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R14-1-20210202","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/106689690000800407","article-title":"Uterine endometrioid carcinoma with small nonvillous papillae: an analysis of 26 cases of a favorable-prognosis tumor to be distinguished from serous carcinoma.","volume":"8","author":"Murray","year":"2000","journal-title":"Int J Surg Pathol"},{"key":"R15-1-20210202","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.path.2010.12.008","article-title":"High-grade endometrial carcinomas.","volume":"4","author":"Oliva","year":"2011","journal-title":"Surg Pathol Clin"},{"key":"R17-1-20210202","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2009.11.012","article-title":"Molecular alterations in uterine serous carcinoma.","volume":"116","author":"Hayes","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R18-1-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","article-title":"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.","volume":"444","author":"Lax","year":"2004","journal-title":"Virchows Arch"},{"key":"R19-1-20210202","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"R20-1-20210202","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/hupa.2001.25929","article-title":"Molecular pathology of endometrial hyperplasia and carcinoma.","volume":"32","author":"Matias-Guiu","year":"2001","journal-title":"Hum Pathol"},{"key":"R23-1-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004347-200404000-00005","article-title":"Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.","volume":"23","author":"Egan","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R24-1-20210202","first-page":"122","article-title":"Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.","volume":"22","author":"Halperin","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"R25-1-20210202","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/modpathol.2008.97","article-title":"Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.","volume":"21","author":"Lomo","year":"2008","journal-title":"Mod Pathol"},{"key":"R26-1-20210202","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/ijgc-00009577-200409000-00030","article-title":"The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma.","volume":"14","author":"Macwhinnie","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R27-1-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004347-199804000-00006","article-title":"Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.","volume":"17","author":"Soslow","year":"1998","journal-title":"Int J Gynecol Pathol"},{"key":"R28-1-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-010-0939-z","article-title":"Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer A clinical-pathological and immunohistochemical study.","volume":"457","author":"Zannoni","year":"2010","journal-title":"Virchows Arch"},{"key":"R29-1-20210202","first-page":"1165","article-title":"MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.","volume":"9","author":"Ambros","year":"1996","journal-title":"Mod Pathol"},{"key":"R30-1-20210202","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2559.1998.00499.x","article-title":"Direct sequencing of the p53 gene shows absence of mutations in endometrioid endometrial adenocarcinomas expressing p53 protein.","volume":"33","author":"Stewart","year":"1998","journal-title":"Histopathology"},{"key":"R31-1-20210202","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PGP.0b013e3181cd6552","article-title":"High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.","volume":"29","author":"Alkushi","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R32-1-20210202","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/modpathol.3800620","article-title":"Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.","volume":"19","author":"Reid-Nicholson","year":"2006","journal-title":"Mod Pathol"},{"key":"R33-1-20210202","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/PAS.0b013e3181ac35f5","article-title":"Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R34-1-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.pgp.0000235065.31301.3e","article-title":"Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.","volume":"26","author":"Chiesa-Vottero","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R35-1-20210202","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ajcp\/94.3.247","article-title":"Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations.","volume":"94","author":"Carcangiu","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"R36-1-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880062","article-title":"Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.","volume":"13","author":"Kounelis","year":"2000","journal-title":"Mod Pathol"},{"key":"R37-1-20210202","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0046-8177(00)80244-0","article-title":"PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.","volume":"31","author":"Bussaglia","year":"2000","journal-title":"Hum Pathol"},{"key":"R38-1-20210202","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res"},{"key":"R39-1-20210202","first-page":"3526","article-title":"Beta-catenin mutation in carcinoma of the uterine endometrium.","volume":"58","author":"Fukuchi","year":"1998","journal-title":"Cancer Res"},{"key":"R40-1-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.0.CO;2-4","article-title":"Nuclear localization of beta-catenin in normal and carcinogenic endometrium.","volume":"25","author":"Nei","year":"1999","journal-title":"Mol Carcinog"},{"key":"R42-1-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2007.09.007","article-title":"An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study.","volume":"108","author":"Grushko","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R43-1-20210202","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1525-1438.2006.00664.x","article-title":"HER-2neu overexpression in uterine papillary serous cancers and its possible therapeutic implications.","volume":"16","author":"Villella","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R44-1-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjc.6604814","article-title":"HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.","volume":"100","author":"Konecny","year":"2009","journal-title":"Br J Cancer"},{"key":"R45-1-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/modpathol.3880531","article-title":"Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.","volume":"15","author":"Al Kushi","year":"2002","journal-title":"Mod Pathol"},{"key":"R46-1-20210202","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0046-8177(98)90197-6","article-title":"Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation.","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"R47-1-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.pas.0000149704.89463.05","article-title":"Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.","volume":"29","author":"Murray","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R48-1-20210202","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00004347-198203000-00005","article-title":"Benign heterologous tissue components associated with endometrial carcinoma.","volume":"1","author":"Nogales","year":"1982","journal-title":"Int J Gynecol Pathol"},{"key":"R49-1-20210202","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/PAS.0b013e3181161ba3","article-title":"Prognostic features of surgical stage I uterine carcinosarcoma.","volume":"31","author":"Ferguson","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R50-1-20210202","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/00000478-199512000-00001","article-title":"Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. A report of 14 cases.","volume":"19","author":"Tornos","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R51-1-20210202","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semdp.2010.09.005","article-title":"Pathologic and molecular features of uterine carcinosarcomas.","volume":"27","author":"Lopez-Garcia","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"R52-1-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004347-199001000-00001","article-title":"Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases.","volume":"9","author":"Silverberg","year":"1990","journal-title":"Int J Gynecol Pathol"},{"key":"R53-1-20210202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00000478-199004000-00002","article-title":"The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study.","volume":"14","author":"Bitterman","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R54-1-20210202","first-page":"583","article-title":"Carcinoma (malignant mixed mullerian mesodermal tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.","volume":"115","author":"Costa","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"R55-1-20210202","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0046-8177(93)90291-N","article-title":"Carcinosarcoma (malignant mixed mullerian mesodermal tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases.","volume":"24","author":"de Brito","year":"1993","journal-title":"Hum Pathol"},{"key":"R56-1-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0046-8177(91)90153-G","article-title":"Malignant mixed mullerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation.","volume":"22","author":"George","year":"1991","journal-title":"Hum Pathol"},{"key":"R57-1-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/94.1.1","article-title":"The immunohistochemical profile of malignant mixed mullerian tumor. Overlap with endometrial adenocarcinoma.","volume":"94","author":"Meis","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"R58-1-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00428-002-0752-4","article-title":"Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.","volume":"442","author":"Alkushi","year":"2003","journal-title":"Virchows Arch"},{"key":"R59-1-20210202","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1309\/AJCPTK87EMMIKPFS","article-title":"S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.","volume":"132","author":"DeRycke","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R60-1-20210202","first-page":"246A","article-title":"Expression of S100P in Benign Endometrium and Endometrial Adenocarcinoma.","volume":"24","author":"Feng","year":"2011","journal-title":"Mod Pathol"},{"key":"R61-1-20210202","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ygyno.2004.05.014","article-title":"Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.","volume":"94","author":"Dupont","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R62-1-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jcp.50.4.328","article-title":"The hormonal receptor status of uterine carcinosarcomas (mixed mullerian tumours): an immunohistochemical study.","volume":"50","author":"Ansink","year":"1997","journal-title":"J Clin Pathol"},{"key":"R63-1-20210202","first-page":"237A","article-title":"Molecular Alterations in Endometrial Carcinosarcomas (ECS).","volume":"24","author":"Biscuola","year":"2011","journal-title":"Mod Pathol"},{"key":"R64-1-20210202","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/PGP.0b013e3181a934e9","article-title":"Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.","volume":"28","author":"Buza","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R65-1-20210202","first-page":"149","article-title":"Aberrant nuclear beta-catenin expression in the spindle or corded cells in so-called corded and hyalinized endometrioid carcinomas. Another critical role of the unique morphological feature.","volume":"24","author":"Wani","year":"2009","journal-title":"Histol Histopathol"},{"key":"R66-1-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.2802","article-title":"Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.","volume":"223","author":"Castilla","year":"2011","journal-title":"J Pathol"},{"key":"R67-1-20210202","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers.","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"R68-1-20210202","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/PAS.0b013e31802ee494","article-title":"Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.","volume":"31","author":"Soslow","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R69-1-20210202","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R70-1-20210202","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.pas.0000171003.72352.9a","article-title":"Undifferentiated carcinoma of the endometrium.","volume":"29","author":"Altrabulsi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R72-1-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/00313020601159494","article-title":"Undifferentiated carcinoma of the endometrium: a review.","volume":"39","author":"Silva","year":"2007","journal-title":"Pathology"},{"key":"R73-1-20210202","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":"Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.","volume":"23","author":"Tafe","year":"2010","journal-title":"Mod Pathol"},{"key":"R74-1-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PGP.0b013e3181895539","article-title":"The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium.","volume":"28","author":"Taraif","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R75-1-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"R76-1-20210202","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R77-1-20210202","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0b013e3180339ed7","article-title":"Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.","volume":"31","author":"Silva","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R78-1-20210202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1525-1438.2006.00494.x","article-title":"Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma.","volume":"16","author":"Arai","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R79-1-20210202","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0046-8177(98)80002-6","article-title":"Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"R80-1-20210202","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00004347-200107000-00008","article-title":"Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract.","volume":"20","author":"Vang","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R81-1-20210202","first-page":"1290","article-title":"E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.","volume":"100","author":"Holcomb","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R82-1-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/147323000903700119","article-title":"E-cadherin expression in endometrial malignancies: comparison between endometrioid and non-endometrioid carcinomas.","volume":"37","author":"Yalta","year":"2009","journal-title":"J Int Med Res"},{"key":"R83-1-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.humpath.2006.12.018","article-title":"Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium.","volume":"38","author":"Yamamoto","year":"2007","journal-title":"Hum Pathol"},{"key":"R84-1-20210202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0b013e3181ff400e","article-title":"Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.","volume":"35","author":"DeLair","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R85-1-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/modpathol.3800492","article-title":"Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.","volume":"19","author":"Kato","year":"2006","journal-title":"Mod Pathol"},{"key":"R86-1-20210202","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/modpathol.3800960","article-title":"Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.","volume":"20","author":"Li","year":"2007","journal-title":"Mod Pathol"},{"key":"R87-1-20210202","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.3800057","article-title":"Molecular characterization of uterine clear cell carcinoma.","volume":"17","author":"An","year":"2004","journal-title":"Mod Pathol"},{"key":"R88-1-20210202","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/modpathol.3800347","article-title":"Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.","volume":"18","author":"Pallares","year":"2005","journal-title":"Mod Pathol"},{"key":"R89-1-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1066896909332117","article-title":"Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.","volume":"18","author":"Carcangiu","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"R90-1-20210202","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/PAS.0b013e3181bc9866","article-title":"Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R91-1-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00125480-200405000-00001","article-title":"Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects.","volume":"11","author":"Clement","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"R92-1-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004347-200404000-00007","article-title":"Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.","volume":"23","author":"Alkushi","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R93-1-20210202","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2008.08.032","article-title":"Wilms tumor gene 1 (WT1) in endometrial carcinoma.","volume":"111","author":"Coosemans","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R94-1-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e3181788546","article-title":"A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.","volume":"33","author":"Kobel","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"Suppl","key":"R95-1-20210202","first-page":"S94","article-title":"Neuroendocrine tumors of the genital tract.","volume":"115","author":"Eichhorn","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R96-1-20210202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000478-199404000-00005","article-title":"Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.","volume":"18","author":"Huntsman","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R98-1-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/pgp.0b013e31806219c5","article-title":"Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.","volume":"27","author":"Mulvany","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R99-1-20210202","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0046-8177(84)80182-3","article-title":"Endometrial carcinoma with argyrophil cells: a histochemical and immunohistochemical analysis.","volume":"15","author":"Aguirre","year":"1984","journal-title":"Hum Pathol"},{"key":"R100-1-20210202","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0046-8177(86)80205-2","article-title":"Immunohistochemical demonstration of chromogranin in endometrial carcinomas with argyrophil cells.","volume":"17","author":"Inoue","year":"1986","journal-title":"Hum Pathol"},{"key":"R101-1-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0020-7292(89)90848-5","article-title":"An immunohistochemical study of neuroendocrine cells in gynecologic tumors.","volume":"29","author":"Ueda","year":"1989","journal-title":"Int J Gynaecol Obstet"},{"key":"R102-1-20210202","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PGP.0b013e31815de006","article-title":"Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis.","volume":"27","author":"Albores-Saavedra","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R103-1-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/modpathol.2008.4","article-title":"Thyroid transcription factor-1 expression in ovarian epithelial neoplasms.","volume":"21","author":"Kubba","year":"2008","journal-title":"Mod Pathol"},{"key":"R104-1-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/PGP.0b013e3181804bc6","article-title":"TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems.","volume":"28","author":"Zhang","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R105-1-20210202","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1933719110368433","article-title":"Minor serous and clear cell components adversely affect prognosis in mixed-type endometrial carcinomas: a clinicopathologic study of 36 stage-I cases.","volume":"17","author":"Quddus","year":"2010","journal-title":"Reprod Sci"},{"key":"R106-1-20210202","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/PAS.0b013e318164edf7","article-title":"Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.","volume":"32","author":"Han","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R107-1-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.semdp.2010.09.003","article-title":"Endometrial carcinomas with ambiguous features.","volume":"27","author":"Soslow","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"R108-1-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.pas.0000152129.81363.d2","article-title":"Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.","volume":"29","author":"Alkushi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R109-1-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","article-title":"Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.","volume":"76","author":"Lynch","year":"2009","journal-title":"Clin Genet"},{"key":"R110-1-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2009.03.003","article-title":"Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.","volume":"114","author":"Resnick","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R111-1-20210202","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/gut.2008.156695","article-title":"A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting.","volume":"57","author":"Ramsoekh","year":"2008","journal-title":"Gut"},{"key":"R112-1-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1897-4287-7-17","article-title":"Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management.","volume":"7","author":"Ramsoekh","year":"2009","journal-title":"Hered Cancer Clin Pract"},{"key":"R113-1-20210202","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.2009.064949","article-title":"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.","volume":"62","author":"Garg","year":"2009","journal-title":"J Clin Pathol"},{"key":"R114-1-20210202","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2007.05.022","article-title":"Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.","volume":"39","author":"Shia","year":"2008","journal-title":"Hum Pathol"},{"key":"R115-1-20210202","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.pas.0000126720.49083.11","article-title":"More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon.","volume":"28","author":"van den Bos","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R116-1-20210202","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1200\/JCO.2008.18.6296","article-title":"Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.","volume":"26","author":"Westin","year":"2008","journal-title":"J Clin Oncol"},{"key":"R118-1-20210202","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2009.11.021","article-title":"Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.","volume":"116","author":"Walsh","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R119-1-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","article-title":"Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.","volume":"10","author":"Shia","year":"2008","journal-title":"J Mol Diagn"},{"key":"R120-1-20210202","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"R121-1-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/hupa.2002.32220","article-title":"Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma.","volume":"33","author":"Peiro","year":"2002","journal-title":"Hum Pathol"},{"key":"R122-1-20210202","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.","volume":"25","author":"Lu","year":"2007","journal-title":"J Clin Oncol"},{"key":"R123-1-20210202","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/15287390902841003","article-title":"Meta-analysis of MSH6 gene mutation frequency in colorectal and endometrial cancers.","volume":"72","author":"Zhao","year":"2009","journal-title":"J Toxicol Environ Health A"},{"key":"R124-1-20210202","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/AOG.0b013e3181b11ecc","article-title":"Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.","volume":"114","author":"Resnick","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R125-1-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R126-1-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1440-1827.2000.01001.x","article-title":"Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study of 100 cases.","volume":"50","author":"Iwata","year":"2000","journal-title":"Pathol Int"},{"key":"R127-1-20210202","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/1097-0142(197604)37:4<1853::AID-CNCR2820370433>3.0.CO;2-E","article-title":"Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical and pathologic analysis of 26 cases.","volume":"37","author":"Kurman","year":"1976","journal-title":"Cancer"},{"key":"R129-1-20210202","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000478-199704000-00003","article-title":"Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients.","volume":"21","author":"Prayson","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R130-1-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00004347-199504000-00012","article-title":"Uterine leiomyosarcoma with clear cell areas.","volume":"14","author":"Silva","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"R131-1-20210202","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/01.pas.0000173232.22117.37","article-title":"Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.","volume":"29","author":"Folpe","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R132-1-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200201000-00001","article-title":"Perivascular epithelioid cell tumor (PEComa) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.","volume":"26","author":"Vang","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R133-1-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2005.08.058","article-title":"Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance.","volume":"100","author":"Baergen","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R134-1-20210202","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0046-8177(99)90296-4","article-title":"Detection of the alpha-subunit of inhibin in trophoblastic neoplasia.","volume":"30","author":"Pelkey","year":"1999","journal-title":"Hum Pathol"},{"key":"R135-1-20210202","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004347-199904000-00008","article-title":"Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.","volume":"18","author":"Shih","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"R136-1-20210202","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0046-8177(99)90095-3","article-title":"Placental site nodule and characterization of distinctive types of intermediate trophoblast.","volume":"30","author":"Shih","year":"1999","journal-title":"Hum Pathol"},{"key":"R137-1-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004347-199510000-00001","article-title":"Alveolar soft-part sarcoma of the female genital tract: a report of nine cases and review of the literature.","volume":"14","author":"Nielsen","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"R138-1-20210202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.pgp.0000148343.07759.e1","article-title":"TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: case report.","volume":"24","author":"Roma","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R139-1-20210202","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/1097-0142(19930915)72:6<1959::AID-CNCR2820720628>3.0.CO;2-P","article-title":"Malignant lymphoma of the uterus. Report of seven cases with immunohistochemical study.","volume":"72","author":"Aozasa","year":"1993","journal-title":"Cancer"},{"key":"R140-1-20210202","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/1097-0142(19840601)53:11<2530::AID-CNCR2820531127>3.0.CO;2-J","article-title":"Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases.","volume":"53","author":"Harris","year":"1984","journal-title":"Cancer"},{"key":"R141-1-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004347-200004000-00006","article-title":"Endometrial carcinoma and non-Hodgkins lymphoma involving the female genital tract: a report of three cases.","volume":"19","author":"Vang","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"R143-1-20210202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/PAS.0b013e318093e421","article-title":"Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature.","volume":"32","author":"Euscher","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R144-1-20210202","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/00000478-200308000-00005","article-title":"Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.","volume":"27","author":"Tambouret","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R145-1-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2559.2002.01462.x","article-title":"Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.","volume":"41","author":"Young","year":"2002","journal-title":"Histopathology"},{"key":"R147-1-20210202","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00000478-199307000-00002","article-title":"Minimal-deviation endometrioid adenocarcinoma of the uterine cervix. A report of five cases of a distinctive neoplasm that may be misinterpreted as benign.","volume":"17","author":"Young","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R148-1-20210202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/PAS.0b013e31820f1cc2","article-title":"Low-grade Mucinous Adenocarcinoma of the Uterine Corpus: A Rare and Deceptively Bland Form of Endometrial Carcinoma.","volume":"35","author":"Fujiwara","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R150-1-20210202","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00404-009-1151-8","article-title":"A reappraisal of three-marker (ERVimCEA), four-marker (ERVimCEAPR), and five-marker (ERVimCEAPRp16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.","volume":"281","author":"Han","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"R151-1-20210202","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/PAS.0b013e3181e3291e","article-title":"A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.","volume":"34","author":"Kong","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R152-1-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004347-200201000-00003","article-title":"A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.","volume":"21","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R153-1-20210202","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(79)92386-9","article-title":"Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens.","volume":"2","author":"Wahlstrom","year":"1979","journal-title":"Lancet"},{"key":"R154-1-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00004347-200201000-00002","article-title":"Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study.","volume":"21","author":"Castrillon","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R155-1-20210202","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00000478-198608000-00007","article-title":"Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns.","volume":"10","author":"Dabbs","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"R156-1-20210202","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0046-8177(96)90371-8","article-title":"The immunohistochemical discrimination of endometrioid adenocarcinomas.","volume":"27","author":"Dabbs","year":"1996","journal-title":"Hum Pathol"},{"key":"R157-1-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004347-200207000-00003","article-title":"Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint.","volume":"21","author":"Kamoi","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R158-1-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1620\/tjem.146.27","article-title":"Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium.","volume":"146","author":"Toki","year":"1985","journal-title":"Tohoku J Exp Med"},{"key":"R159-1-20210202","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00125480-200405000-00004","article-title":"A critical appraisal of the value of immunohistochemistry in diagnosis of uterine neoplasms.","volume":"11","author":"McCluggage","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"R160-1-20210202","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000478-200402000-00002","article-title":"Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.","volume":"28","author":"Ansari-Lari","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R161-1-20210202","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/00000478-200208000-00004","article-title":"Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas.","volume":"26","author":"Staebler","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R162-1-20210202","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1158\/1078-0432.CCR-06-0398","article-title":"An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.","volume":"12","author":"Chiarelli","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R164-1-20210202","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/PAS.0b013e3181971fdd","article-title":"Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R165-1-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5858\/2008-132-175-IIGP","article-title":"Immunohistochemistry in gynecologic pathology.","volume":"132","author":"Deavers","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R166-1-20210202","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/PGP.0b013e3181b8e951","article-title":"Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.","volume":"29","author":"Jiang","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R167-1-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1699-0463.1997.tb00575.x","article-title":"Adenocarcinoma of the cervix and adenocarcinoma of the endometrium: distinction with PCR-mediated detection of HPV DNA.","volume":"105","author":"Hording","year":"1997","journal-title":"APMIS"},{"key":"R168-1-20210202","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/gyno.1996.0126","article-title":"Human papillomavirus detection of endometrioid carcinoma with squamous differentiation of the uterine corpus.","volume":"61","author":"Czerwenka","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R169-1-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0046-8177(95)90171-X","article-title":"Association of human papillomavirus with malignant and premalignant lesions of the uterine endometrium.","volume":"26","author":"Fujita","year":"1995","journal-title":"Hum Pathol"},{"key":"R170-1-20210202","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/PGP.0b013e3181c043bc","article-title":"True cytokeratin 818 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.","volume":"29","author":"Hsu","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R171-1-20210202","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/PGP.0b013e31815d05ec","article-title":"Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.","volume":"27","author":"Onuma","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R172-1-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1525-1438.2003.13025.x","article-title":"Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.","volume":"13","author":"Halperin","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"R173-1-20210202","doi-asserted-by":"crossref","first-page":"465162","DOI":"10.1155\/2010\/465162","article-title":"The Association between Primary Endometrioid Carcinoma of the Ovary and Synchronous Malignancy of the Endometrium.","volume":"2010","author":"van Niekerk","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"R174-1-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2559.2009.03367.x","article-title":"Synchronous tumours of the female genital tract.","volume":"56","author":"Singh","year":"2010","journal-title":"Histopathology"},{"key":"R175-1-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R176-1-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1525-1438.2007.00975.x","article-title":"Synchronous primary cancers of the endometrium and ovary.","volume":"18","author":"Chiang","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R178-1-20210202","first-page":"403","article-title":"Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.","volume":"9","author":"Oranratanaphan","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"key":"R179-1-20210202","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004347-200404000-00004","article-title":"WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.","volume":"23","author":"Acs","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R180-1-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma.","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"R181-1-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/01.pas.0000168174.25664.04","article-title":"Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps.","volume":"29","author":"Euscher","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R183-1-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas.","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R185-1-20210202","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/modpathol.2008.108","article-title":"Immunophenotyping of serous carcinoma of the female genital tract.","volume":"21","author":"Nofech-Mozes","year":"2008","journal-title":"Mod Pathol"},{"key":"R187-1-20210202","first-page":"1271","article-title":"Overexpression of HER-2neu in uterine serous papillary cancer.","volume":"8","author":"Santin","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R189-1-20210202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/hupa.2002.124118","article-title":"Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.","volume":"33","author":"Fujii","year":"2002","journal-title":"Hum Pathol"},{"key":"R191-1-20210202","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.humpath.2005.03.005","article-title":"Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.","volume":"36","author":"Irving","year":"2005","journal-title":"Hum Pathol"},{"key":"R192-1-20210202","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.humpath.2004.08.011","article-title":"Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis.","volume":"35","author":"Kaneki","year":"2004","journal-title":"Hum Pathol"},{"key":"R193-1-20210202","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2559.2008.03107.x","article-title":"The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus.","volume":"53","author":"Mhawech-Fauceglia","year":"2008","journal-title":"Histopathology"},{"key":"R195-1-20210202","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/1078-0432.CCR-08-0373","article-title":"Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.","volume":"14","author":"Ramus","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R196-1-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00019606-200306000-00002","article-title":"PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus.","volume":"12","author":"Ricci","year":"2003","journal-title":"Diagn Mol Pathol"},{"key":"R197-1-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/1097-0142(19950815)76:4<650::AID-CNCR2820760417>3.0.CO;2-1","article-title":"Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium.","volume":"76","author":"Shenson","year":"1995","journal-title":"Cancer"},{"key":"R198-1-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/gyno.1998.5084","article-title":"Amplification and expression of the c-erbB-2 oncogene in Mullerian-derived genital-tract tumors.","volume":"71","author":"Manavi","year":"1998","journal-title":"Gynecol Oncol"},{"key":"R199-1-20210202","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/1097-0142(19821115)50:10<2163::AID-CNCR2820501032>3.0.CO;2-F","article-title":"Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases.","volume":"50","author":"Kumar","year":"1982","journal-title":"Cancer"},{"key":"R200-1-20210202","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/1097-0142(19840501)53:9<1978::AID-CNCR2820530929>3.0.CO;2-1","article-title":"Metastases to the female genital tract. Analysis of 325 cases.","volume":"53","author":"Mazur","year":"1984","journal-title":"Cancer"},{"key":"R201-1-20210202","first-page":"21","article-title":"Uterine metastases of extragenital carcinomas.","volume":"80","author":"Di Bonito","year":"1985","journal-title":"Rev Fr Gynecol Obstet"},{"key":"R202-1-20210202","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.revmed.2007.12.013","article-title":"Uterine metastasis of a small-cell lung cancer.","volume":"29","author":"Chargari","year":"2008","journal-title":"Rev Med Interne"},{"key":"R203-1-20210202","first-page":"1066","article-title":"Well-differentiated pulmonary neuroendocrine carcinoma metastatic to the endometrium: a case report.","volume":"9","author":"Jordan","year":"1996","journal-title":"Mod Pathol"},{"key":"R204-1-20210202","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PGP.0b013e318192927d","article-title":"Metastasis of adenocarcinoma of the gall bladder to an endometrial polyp detected by endometrial curettage: case report and review of the literature.","volume":"28","author":"Kefeli","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R205-1-20210202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4143\/crt.2008.40.3.141","article-title":"Hepatocellular carcinoma presenting as uterine metastasis.","volume":"40","author":"Kang","year":"2008","journal-title":"Cancer Res Treat"},{"key":"R206-1-20210202","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1525-1438.2006.00668.x","article-title":"Uterine metastasis from hepatocellular carcinoma: A case report.","volume":"16","author":"Ryo","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R207-1-20210202","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s00268-005-0472-4","article-title":"Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.","volume":"30","author":"Benbassat","year":"2006","journal-title":"World J Surg"},{"key":"R208-1-20210202","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1089\/thy.2005.15.1309","article-title":"Hurthle cell carcinoma metastatic to uterus.","volume":"15","author":"Benbassat","year":"2005","journal-title":"Thyroid"},{"key":"R209-1-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/(SICI)1097-0339(199910)21:4<271::AID-DC8>3.0.CO;2-A","article-title":"Metastatic salivary duct carcinoma to the uterus: report of a case diagnosed by cervical smear.","volume":"21","author":"Vinette-Leduc","year":"1999","journal-title":"Diagn Cytopathol"},{"key":"R210-1-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0022-5347(17)69249-8","article-title":"Metastases to endometrium and skin from carcinoma of kidney; report of a case and review of literature.","volume":"60","author":"Ratner","year":"1948","journal-title":"J Urol"},{"key":"R211-1-20210202","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.anndiagpath.2005.03.003","article-title":"Metastatic breast lobular carcinoma to tamoxifen-associated endometrial polyp: case report and literature review.","volume":"9","author":"Al-Brahim","year":"2005","journal-title":"Ann Diagn Pathol"},{"key":"R213-1-20210202","first-page":"666","article-title":"Metastasis from breast carcinoma to endometrial polyp.","volume":"29","author":"Aydin","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"key":"R214-1-20210202","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.MP.0000062655.62606.86","article-title":"Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.","volume":"16","author":"Houghton","year":"2003","journal-title":"Mod Pathol"},{"key":"R215-1-20210202","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s004280000379","article-title":"Metastasis from apocrine carcinoma of the breast to an endometrial polyp.","volume":"438","author":"Lambot","year":"2001","journal-title":"Virchows Arch"},{"key":"R216-1-20210202","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1600-0463.2008.00940.x","article-title":"Lobular carcinoma metastasis to endometrial polyp unrelated to tamoxifen. Report of a case and review of the literature.","volume":"116","author":"Manipadam","year":"2008","journal-title":"APMIS"},{"key":"R217-1-20210202","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0090-8258(90)90408-D","article-title":"Breast carcinoma metastatic to endometrial polyp.","volume":"39","author":"Sullivan","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R218-1-20210202","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ygyno.2005.03.019","article-title":"Metastasis from breast carcinoma to a tamoxifen-related endometrial polyp.","volume":"97","author":"Acikalin","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R219-1-20210202","first-page":"697","article-title":"Cutaneous malignant melanoma metastatic to a uterine leiomyoma: a case report.","volume":"53","author":"Bakelaar","year":"2008","journal-title":"J Reprod Med"},{"key":"R220-1-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9378(71)90789-7","article-title":"Uterine leiomyoma containing metastatic breast carcinoma.","volume":"111","author":"Banooni","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"R221-1-20210202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1993.1282","article-title":"Breast carcinoma metastatic to uterine leiomyoma.","volume":"51","author":"Beattie","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R222-1-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12282-008-0069-5","article-title":"Metastasis of breast cancer to a uterine leiomyoma.","volume":"16","author":"Kondo","year":"2009","journal-title":"Breast Cancer"},{"key":"R223-1-20210202","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2559.1998.0434g.x","article-title":"Fortuitous diagnosis in a uterine leiomyoma of metastatic lobular carcinoma of the breast.","volume":"32","author":"Liebmann","year":"1998","journal-title":"Histopathology"},{"key":"R224-1-20210202","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1074-3804(98)80094-7","article-title":"Uterine leiomyoma metastasis as a first sign of breast cancer.","volume":"5","author":"Minelli","year":"1998","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"R225-1-20210202","first-page":"476","article-title":"Extragenital metastases to uterine leiomyomata. A case report.","volume":"37","author":"OBrien","year":"1992","journal-title":"J Reprod Med"},{"key":"R226-1-20210202","first-page":"285","article-title":"Breast cancer metastatic to uterine leiomyoma.","volume":"76","author":"Spiro","year":"1979","journal-title":"J Med Soc N J"},{"key":"R228-1-20210202","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0301-2115(02)00152-5","article-title":"Uterine lipoleiomyoma containing metastatic breast carcinoma: a case with two unusual pathologies.","volume":"106","author":"Uner","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R229-1-20210202","first-page":"334","article-title":"Breast cancer metastatic to uterine leiomyosarcoma. A case report and review of the literature.","volume":"24","author":"Ricci","year":"2003","journal-title":"Eur J Gynaecol Oncol"},{"key":"R230-1-20210202","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2004.09.064","article-title":"Metastases of breast carcinoma to the uterus. Report of two cases, one harboring a primary endometrioid carcinoma, with review of the literature.","volume":"96","author":"Scopa","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R231-1-20210202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1440-1827.2008.02230.x","article-title":"Metastatic breast carcinoma identified in a uterine leiomyosarcoma.","volume":"58","author":"Yasuhara","year":"2008","journal-title":"Pathol Int"},{"key":"R232-1-20210202","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1525-1438.2007.01137.x","article-title":"Mammaglobin B expression in human endometrial cancer.","volume":"18","author":"Tassi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R233-1-20210202","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R235-1-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcp\/107.1.12","article-title":"Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.","volume":"107","author":"Brown","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"R237-1-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PAI.0b013e318174f012","article-title":"Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.","volume":"17","author":"Park","year":"2009","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R238-1-20210202","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2559.2009.03248.x","article-title":"Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules.","volume":"54","author":"Wani","year":"2009","journal-title":"Histopathology"},{"key":"R239-1-20210202","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.humpath.2007.07.019","article-title":"Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation.","volume":"39","author":"Wani","year":"2008","journal-title":"Hum Pathol"},{"key":"R240-1-20210202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1309\/5MHB-K6XX-QV50-PCJQ","article-title":"Estrogen and progesterone receptors in colon tumors.","volume":"113","author":"Slattery","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R241-1-20210202","first-page":"469","article-title":"Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues.","volume":"6","author":"Bur","year":"1993","journal-title":"Mod Pathol"},{"key":"R242-1-20210202","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<357::AID-IJC9>3.0.CO;2-Q","article-title":"Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer.","volume":"67","author":"Kaiser","year":"1996","journal-title":"Int J Cancer"},{"key":"R243-1-20210202","first-page":"3155","article-title":"Estrogen and progesterone receptors in gastric and colorectal cancer.","volume":"46","author":"Oshima","year":"1999","journal-title":"Hepatogastroenterology"},{"issue":"6B","key":"R244-1-20210202","first-page":"3803","article-title":"Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study.","volume":"16","author":"Su","year":"1996","journal-title":"Anticancer Res"},{"key":"R245-1-20210202","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/PAS.0b013e3181131e21","article-title":"Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.","volume":"31","author":"Siami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R246-1-20210202","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":"CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.","volume":"43","author":"McCluggage","year":"2003","journal-title":"Histopathology"},{"key":"R247-1-20210202","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAI.0b013e3181d712ef","article-title":"PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: A comprehensive immunohistochemical study.","volume":"18","author":"Zhai","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00125480-201111000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T05:16:19Z","timestamp":1639113379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-201111000-00001"}},"subtitle":["A Review Emphasizing Overlapping and Distinctive Morphological and Immunohistochemical Features"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":223,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e318234ab18","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}